Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Patient Follow-up Program to Assess Asthma Control in Patients Using Symbicort® as Maintenance and Relief Therapy in a Single Inhaler (Symbicort® SMART: Budesonide/Formoterol 160/4.5 Mcg, 1 or 2 Inhalations x 2 Times Plus Additional Inhalations as Needed)

NCT00524641 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00524641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00524641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Patient Follow-up Program to Assess Asthma Control in Patients Using Symbicort® as Maintenance and Relief Therapy in a Single Inhaler (Symbicort® SMART: Budesonide/Formoterol 160/4.5 Mcg, 1 or 2 Inhalations x 2 Times Plus Additional Inhalations as Needed)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
July 31, 2007
Completion date
April 30, 2008
Enrollment
1,254 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

asthma